---
schema_version: '1.0'
id: news-20260901-e0e6a4
title: 'CARMAT SAS: EFICAS Study Results Confirm the Clinical Performance of the Aeson
  Total Artificial Heart as a Bridge-to-Transplant Therapy'
url: https://www.finanznachrichten.de/nachrichten-2026-09/69458267-carmat-sas-eficas-study-results-confirm-the-clinical-performance-of-the-aeson-total-artificial-heart-as-a-bridge-to-transplant-therapy-004.htm
url_hash: e0e6a451564a9cae0f4ada0693328ae15a78e2401d25f84b63dff0409328a225
canonical_url: https://www.finanznachrichten.de/nachrichten-2026-09/69458267-carmat-sas-eficas-study-results-confirm-the-clinical-performance-of-the-aeson-total-artificial-heart-as-a-bridge-to-transplant-therapy-004.htm
source: www.finanznachrichten.de
category: news/world
category_raw: world_general
region: null
tags:
- world_general
lang: null
published_at: null
fetched_at: '2026-09-01T07:17:40.897979Z'
updated_at: '2026-09-01T07:23:15Z'
status: published
content_hash: null
content_changed_at: null
license_note: link-only
summary: null
summary_source: null
summary_en: null
summary_omitted_reason: license_restricted
redistribution: false
keywords_en:
- Aeson
- Artificial
- Bridge-to-Transplant
- CARMAT
- CARMAT SAS
- Clinical
- Confirm
- CRS Clinical Research Services Berlin GmbH (CRS Berlin
- Danish Study
- EFICAS
- EFICAS (NCT04475393
- EFICAS Study Results
- Heart
- international affairs
- Performance
- Results
- SAS
- Sascha Radetsky
- Study
- the
- THE ANSWER
- Therapy
- Total
- world_general
entities_en:
- name: CARMAT SAS
  type: organization
- name: CRS Clinical Research Services Berlin GmbH (CRS Berlin
  type: artifact
- name: Danish Study
  type: event
- name: EFICAS (NCT04475393
  type: data
- name: EFICAS Study Results
  type: event
- name: Sascha Radetsky
  type: person
- name: THE ANSWER
  type: organization
topics_en:
- international affairs
numeric_facts: []
entities:
- name: CARMAT SAS
  type: organization
- name: Sascha Radetsky
  type: person
- name: EFICAS (NCT04475393
  type: data
- name: Danish Study
  type: event
- name: EFICAS Study Results
  type: event
- name: THE ANSWER
  type: organization
- name: CRS Clinical Research Services Berlin GmbH (CRS Berlin
  type: artifact
key_facts: []
related: []
related_auto:
- name: Type 2 Diabetes Patients
  type: concept
  weight: 1.0
- name: Statins and Dementia Risk
  type: concept
  weight: 1.0
- name: BING / top
  type: data
  weight: 1.0
- name: 紀平梨花
  type: person
  weight: 1.0
- name: 西山真瑙
  type: person
  weight: 1.0
computed_at: '2026-09-01T07:23:00Z'
---

# CARMAT SAS: EFICAS Study Results Confirm the Clinical Performance of the Aeson Total Artificial Heart as a Bridge-to-Transplant Therapy

## TL;DR
（要約なし・原文はリンク先を参照 / No summary available; see the source link.）

## Key Points
- world_general

## Details
(本文なし。リンク先参照)

## Source
元記事: [CARMAT SAS: EFICAS Study Results Confirm the Clinical Performance of the Aeson Total Artificial Heart as a Bridge-to-Transplant Therapy](https://www.finanznachrichten.de/nachrichten-2026-09/69458267-carmat-sas-eficas-study-results-confirm-the-clinical-performance-of-the-aeson-total-artificial-heart-as-a-bridge-to-transplant-therapy-004.htm)